LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Trial Profile

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs LEO 32731 (Primary)
  • Indications Plaque psoriasis; Psoriatic arthritis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 14 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 22 Sep 2016 Status changed from not yet recruiting to recruiting.
    • 05 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top